Dr Nk Arora

Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.

Pointing out that there has been no increase in hospital admissions and the death count due to Covid, he said the new mutation of the virus is more contagious but isn't causing serious disease.

India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.

Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.

India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai

Monkeypox outbreak has been witnessed in nearly 20 countries, however, no suspected cases of the disease have been detected in India so far, referring to which, a health expert on Wednesday said that it is not as contagious as COVID-19.

India will likely begin inoculating children in the 12-14 age groups against Covid from March as the 15-18 population will mostly be fully vaccinated by then, Dr NK Arora, Chairman of the COVID-19 working group NTAGI, said today.

Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)

A decision on which vaccines will be given as boosters will be taken within two days, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV today.

A large chunk of Omicron cases in India as the country faces a third wave of the COVID-19 pandemic have been reported from big cities, the head of the country's vaccine task force Dr NK Arora told NDTV today, adding the third wave is here.

Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.

A comprehensive policy on additional Covid vaccine doses for immunocompromised people will be drawn up over the next two weeks, Dr NK Arora, chairman of the country's Covid Task Force, has told NDTV.

Vaccination for children with comorbities will begin in December and that will be followed by the vaccine rollout for healthy children, somewhere in the first quarter of next year, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV.

With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.

It took India a little over nine months to achieve the one billion vaccination milestone, but the next billion doses will only take about three to four months, said Dr NK Arora, who heads the National Expert Group on Vaccine Administration

Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.

Pointing out that there has been no increase in hospital admissions and the death count due to Covid, he said the new mutation of the virus is more contagious but isn't causing serious disease.

India's fight against COVID-19 is shaping up much better than neighbouring China due to robust "hybrid immunity", the head of the country's vaccine task force told NDTV today in an exclusive interview.

Amid the rising COVID cases in China, a top Indian health expert on Tuesday cautioned the people while asking them to keep a close vigil on the situation in the country.

India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai

Monkeypox outbreak has been witnessed in nearly 20 countries, however, no suspected cases of the disease have been detected in India so far, referring to which, a health expert on Wednesday said that it is not as contagious as COVID-19.

India will likely begin inoculating children in the 12-14 age groups against Covid from March as the 15-18 population will mostly be fully vaccinated by then, Dr NK Arora, Chairman of the COVID-19 working group NTAGI, said today.

Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)

A decision on which vaccines will be given as boosters will be taken within two days, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV today.

A large chunk of Omicron cases in India as the country faces a third wave of the COVID-19 pandemic have been reported from big cities, the head of the country's vaccine task force Dr NK Arora told NDTV today, adding the third wave is here.

Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.

A comprehensive policy on additional Covid vaccine doses for immunocompromised people will be drawn up over the next two weeks, Dr NK Arora, chairman of the country's Covid Task Force, has told NDTV.

Vaccination for children with comorbities will begin in December and that will be followed by the vaccine rollout for healthy children, somewhere in the first quarter of next year, Dr NK Arora, chairman of the country's Covid Task Force, told NDTV.

With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.

It took India a little over nine months to achieve the one billion vaccination milestone, but the next billion doses will only take about three to four months, said Dr NK Arora, who heads the National Expert Group on Vaccine Administration